Zydus Lifesciences said that it has received final approval from the United States Food and Drug Administration (US FDA) to manufacture Methenamine Hippurate Tablets.

Zydus Lifesciences has received USFDA approval to manufacture its generic version of Methenamine Hippurate tablets for ...

The tablets are indicated for prophylactic or suppressive treatment of frequently recurring urinary tract infections when ...

Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets, strengthening position in US market.

Ahmedabad: Zydus Lifesciences Limited has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram ...

Amid a rapidly evolving landscape in the treatment of muscle-invasive bladder cancer (MIBC), new findings presented at the 2025 ASCO Genitourinary Cancers Symposium in San Francisco, California, ...

The healthcare space changes every single time and a good example to use would be how one is able to reach certain medical ...

Zydus Lifescienceshas received final approval from the United States Food and Drug Administration (USFDA) to manufacture Methenamine Hippurate Tablets USP, 1 gram (USRLD: Hiprex Tablets, 1 gram).

Kidney-related problems are on the rise among Gen Z in Hyderabad and Telangana, with concerns over elevated creatinine levels ...

Realizing this could be a critical emergency requiring neurosurgical intervention, I knew we had to get to the ER as quickly ...

The Amazon One Medical office in Edgewater is the first of three locations coming to New Jersey through a partnership with Hackensack Meridian Health. Additional locations are expected to open later ...